MedPath

Effect of Diets on the Gut Microbiota Composition and Cardiometabolic Wellbeing

Not Applicable
Completed
Conditions
Healthy
Registration Number
NCT03539666
Lead Sponsor
South Dakota State University
Brief Summary

The project will characterize human gut microbiome response to two different diets and the possible physiological and biochemical implications of such response on cardiometabolic risk factors. The study will use controlled-feeding, systems-biology, metagenomic, and metabolomic approaches to examine American dietary patterns.

Detailed Description

The study will use controlled-feeding, systems-biology, metagenomic, and metabolomic approaches to examine American dietary patterns.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • generally good health status based on one routine physical in the past 15 months, current health status
  • normal HbA1C, weigh 110 lb or more
  • Age 50 years or more, generally healthy, all races and both sexes
  • generally practicing a meat-based dietary pattern, do not have any special dietary requirement, and
  • willingness to comply with the study protocol, including on-site meal consumption and sample/data collection.
Exclusion Criteria
  • medication usage, probiotic, long-term antibiotic, and tobacco/drug/alcohol use
  • Not on any special diet within 3 months of recruitment, and do not have any intention to lose weight.
  • impaired kidney functions
  • Active history of cancer, diabetes, heart, liver, and kidney diseases
  • major gastrointestinal disorders in the past 3 months
  • history of heart attacks or stroke
  • Unable to meet in-person visit requirements for dining, picking up meals, and tests
  • Any mental health condition that would affect the ability to provide written informed consent.
  • If they had not had a routine health checkup during the 12 months prior to recruitment.
  • If they were unwilling to abstain from taking nutritional supplements, alcohol, non-study foods, and beverage during the study period.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Microbiota-dependent TMAO-response, measured as serum concentration10 days per diet arm

targeted sequencing

Serum concentration of biogenic amine metabolites10 days per diet arm

Metabolomics

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

South Dakota State University, Wagner Hall 416

🇺🇸

Brookings, South Dakota, United States

South Dakota State University, Wagner Hall 416
🇺🇸Brookings, South Dakota, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.